What are the risks of taking psychedelics without a guide or sitter?

The research that describes psychedelics as relatively safe describes a container: screened participants, preparation, a controlled setting, and trained people present. Without it, the documented risks are an unchecked health or medication contraindication, a difficult experience with no one there to keep you safe, mixing with other substances, an unprepared setting, and legal exposure. In a large survey, about 0.2% of past-year psilocybin mushroom users sought emergency care and nearly all recovered within 24 hours, but the Johns Hopkins safety guidelines warn that in "unprepared individuals or uncontrolled situations" adverse effects may potentially escalate.

Most of what is reassuring about psychedelic safety comes from studies and programs in which people were screened, prepared, and supported. This page separates what the evidence says about each of those pieces and what is known, and not known, about going without them.

1. The safety evidence describes a container, not the substance alone

The 2008 Johns Hopkins safety guidelines are blunt about this: "in unprepared individuals or uncontrolled situations any of these effects may potentially escalate" (Johnson, Richards & Griffiths, 2008). Their recommended protocol includes health screening, at least eight contact hours over at least four meetings before a session, at least two monitors with one always in the room, a next-day follow-up, and no driving afterward. When someone takes part without those pieces, the favorable numbers in the clinical research no longer describe their situation.

2. Risk 1: A contraindication nobody checked

Research protocols exclude people with a personal or family history of psychosis or bipolar disorder, certain cardiovascular conditions, and certain medications (see who should not take psychedelics and psilocybin and SSRIs). The Hopkins guidelines treat screening as a core safety step. Without a screening conversation, a person may not know whether they are in an excluded group until something goes wrong. A guide is not a doctor and can't clear you medically, but a good one will ask about this and tell you when to talk to a clinician first.

3. Risk 2: A hard moment with no one there

The survey doesn't say whether those people were alone. But the 2016 survey of 1,993 people describing their worst psilocybin experience found 10.7% said they put themselves or others at risk of physical harm and 2.6% said they acted aggressively or violently (Carbonaro et al., as summarized by ScienceDaily). A follow-up analysis of the same kind of survey data (n = 1,993 and n = 981) noted that interpersonal support that may buffer challenging experiences is "variable and in many cases absent" in these uncontrolled sessions, whereas supervised research provides it by design. Panic is the usual symptom; the danger is what an unsupported, frightened person does with it.

4. Risk 3: Mixing, and an unprepared environment

Both the survey data above and the safety guidelines point to the same two factors: other substances and the physical and emotional setting. Alcohol, cannabis, and other drugs were common among people who ended up seeking emergency care in the Global Drug Survey (cannabis 37%, alcohol 32%). The Hopkins guidelines also warn that an overly clinical room can raise anxiety and that sharp or breakable objects should be removed. The point is not that a particular room is required, but that setting is a real variable that someone should be thinking about before the day.

5. Risk 4: What is happening more broadly

6. Risk 5: The legal picture

Psilocybin remains illegal under federal law. As of October 2026, the main regulated routes are Oregon's licensed service-center program and Colorado's licensed healing centers (both adults 21+), and New Mexico's medical program is still being set up. Outside those programs, possession and use carry legal risk that varies by state. See where psychedelics are legal or decriminalized in the US for the current state-by-state picture. Guides Collective does not provide or facilitate access to any substances.

What "with support" means in a regulated program

In Oregon, every client completes a preparation session covering intake, consent, and a safety and support plan. Facilitators are trained to respond when an experience becomes challenging, may use supportive touch only with prior documented consent, are required to contact emergency services in a medical or behavioral emergency, and must contact every client within 72 hours afterward. Facilitators don't provide medical care or direct the experience, and the program is not a guarantee against harm (Oregon Health Authority).

Frequently asked questions

Sources

• Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. J Psychopharmacol. 2022;36(8):965–973 (2017 Global Drug Survey data).
• Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. J Psychopharmacol. 2008;22(6):603–620.
• Carbonaro TM et al. Survey study of challenging experiences after ingesting psilocybin mushrooms. J Psychopharmacol. 2016 (summary via ScienceDaily).
• Follow-up analysis of two online surveys of challenging psilocybin experiences (n = 1,993 and n = 981), PubMed Central PMC5540159.
• Denver Health. Study shows magic mushroom use increasing (April 2025), reporting Black JC, Rockhill KM et al., "The Rise of Psilocybin Use in the United States, a Multi-Source Observational Study," Annals of Internal Medicine.
• Oregon Health Authority, Oregon Psilocybin Services. OPS Health and Safety fact sheet.
• Oregon Health Authority, Oregon Psilocybin Services. Facilitator Scope of Practice fact sheet.